In Brief: MiniMed
This article was originally published in The Gray Sheet
MiniMed: Names Terrance Gregg president and chief operating officer, filling a position left vacant by Peter Rule in October 1995. Gregg joined MiniMed in September 1994 as the firm's VP-regulatory affairs and clinical research. Before joining MiniMed, he served as VP-governmental affairs for Smith & Nephew's Ioptex Research division...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.